Bulletin from the extraordinary general meeting of Xspray Pharma AB (publ)
On 20 February, 2018, Xspray Pharma AB (publ) held an extraordinary general meeting. The following resolution, among others, were passed at the general meeting.Directed issue of shares The general meeting resolved, in accordance with the board of directors’ proposal, to carry out a directed issue of not more than 1,350,000 new shares, entailing an increase in the share capital of not more than SEK 1,350,000. The right to subscribe for the new shares in the directed issue shall, with deviation from the shareholders’ pre-emption rights, be granted to a limited number of strategic or